Physician

Akash Shah, M.D.

According to 2025 Medicare claims, Akash Shah, M.D. (NPI: 1912318296) practices hospice and palliative care in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 10016-6402.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 139 traditional Medicare patients, billed 383 HCPCS/CPT codes, and received $45,820 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 711 prescription claims across 152 beneficiaries totaling $35,453 in drug costs, led by Xtampza Er (Oxycodone Myristate). 2016 DME data shows 22 claims. Open Payments data shows 2 records totaling $121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,966 and ending at $35,453. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	57	90	$8,709
2019	147	337	$30,502
2020	152	327	$30,377
2021	119	325	$29,658
2022	129	333	$29,306
2023	102	270	$24,085
2024	139	383	$45,820

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	73	402	$15,966
2016	96	713	$30,287
2017	77	435	$19,935
2018	37	84	$5,731
2019	83	201	$15,509
2020	70	188	$8,017
2021	173	600	$32,976
2022	162	648	$46,097
2023	124	544	$29,492
2024	152	711	$35,453

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	22	$162
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	11	11	$180
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	27	30	$156
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	66	66	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	86	248	$111
99443	Telephone medical discussion with physician, 21-30 minutes	13	18	$107

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	17	495	$6,910
Fentanyl	Fentanyl	55	1,582	$4,786
Oxycodone Hcl	Oxycodone Hcl	144	2,226	$2,496
Pregabalin	Pregabalin	22	840	$1,275
Naloxone Hcl	Naloxone Hcl	15	206	$855

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$121	Kerecis Limited
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Akash Shah, M.D.?

Tedicare shows public-source Medicare data for Akash Shah, M.D. (NPI 1912318296), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akash Shah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Akash Shah, M.D.?

Akash Shah, M.D. is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Akash Shah, M.D. have Open Payments data?

Akash Shah, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.